BioCorRx Inc. (BICX) — Current Report

Key Insights

• BioCorRx Inc. has entered into a stock exchange agreement with its majority-owned subsidiary BioCorRx Pharmaceuticals, Inc., which is intended to help the company acquire full control of the subsidiary.
• The exchange of shares between BioCorRx Inc. and the shareholders is structured as a tax-free reorganization under Section 368(a)(1)(B) of the Internal Revenue Code.
• The shareholders who are transferring their BioCorRx Pharmaceuticals shares to the parent company are also being granted certain registration rights for the parent company shares they receive in return.